Tumor type | Pathway | Differentiation | Biological function(s) | Ref |
---|---|---|---|---|
BC | MCT-1/miR-34a/IL-6/IL-6R | Pro-M2 polarization | Promote EMT and stemness | [55] |
 | MiR-138-5p /KDM6B | Anti-M1 + Pro-M2 polarization | Promote metastasis to the lung | [56] |
 | Lactate/Gpr132 | Pro-M2 polarization | Facilitate tumor adhesion, migration, and invasion | [57] |
 | Lactate/HIF-1α/STAT3 | Pro-M2 polarization | Lead to endocrine therapy resistance | [58] |
 | MiR-200c/PAI-2 q15.6 | Pro-M2 polarization | Promote the cell migration ability | [59] |
 | PS/MERTK/STAT3/JMJD3/IRF4 | Pro-M2 polarization | Promote tumor growth | [60] |
Ovarian cancer | CircITGB6/IGF2BP2/FGF9 | Pro-M2 polarization | Mediate resistance to cisplatin | [61] |
 | CircATP2B4/miR-532-3p/SREBF1/PI3Kα/AKT | Pro-M2 polarization | Promote tumor metastasis | [62] |
 | ETS1/αvβ5/AKT/Sp1 | Pro-M2 polarization | Promote omental metastasis | [63] |
LCA | CSF1R/AKT | Pro-M2 polarization | Suppress antitumor immune responses | [64] |
 | Src/CD155/MIF | Pro-M2 polarization | Facilitate distant metastasis | [65] |
 | Succinate/SUCNR1/PI3K-HIF-1α | Pro-M2 polarization | Promote tumor metastasis | [66] |
 | PIM1/NF-κB/CCL2/CCR22 | Pro-M2 polarization | Promote tumor progression and immune evasion | [67] |
 | MiR-19b-3p/PTPRD/STAT3 | Pro-M2 polarization | Promote tumor metastasis | [68] |
 | MiR-21-5p/PTEN | Anti-M2 polarization | Attenuate apoptotic and promote metastasis | [69] |
GC | TLR4/PI3K/Akt | Pro-M2 polarization | Increase the migration and invasion abilities | [70] |
 | PLXNC1/MEK1/MSK1/CREB1/miR-92b-5p/STAT3 | Pro-M2 polarization | Promote tumor growth | [71] |
 | CircATP8A1/miR-1-3p/STAT6 | Pro-M2 polarization | Promote proliferation and migration | [72] |
HCC | AKT/Ras | Pro-M2 polarization | Impair enrichment of cytotoxic T cells | [73] |
 | MiR-206/KLF4/NF-κB | Pro-M1 polarization | Enhance expansion and migration of CD8 + T cells | [73] |
CRC | PKN2/DUSP6-Erk1/2 | Anti-M2 polarization | Inhibit tumor growth | [74] |
 | SPON2/integrin β1/PYK2 | Pro-M2 polarization | Promote tumor growth and metastasis | [75] |
 | IL10R/Wnt5a/CaMKII/ERK/STAT3/IL-10 | Pro-M2 polarization | Promote tumor growth and metastasis | [76] |
 | CTSK/TLR4/PI3K/AKT/mTOR | Pro-M2 polarization | Promote migration and motility ability of CRC cells | [77] |
 | HnRNPA1miR-106a-5pJAK2/STAT3 | Pro-M2 polarization | Promote CRC liver metastasis | [78] |
 | circPOLQ/miR-379-3p/IL-10/STAT3 | Pro-M2 polarization | Promote tumor invasion and migration | [79] |
PC | FGD5-AS1/p300/STAT3/NF-κB | Pro-M2 polarization | Promote tumor progression | [80] |
 | Lactate/Gpr132 | Pro-M2 polarization | Support growth and metastasis | [81] |
 | ANXA2/MMP28/MAPK/JNK/IL-8 | Pro-M2 polarization | Promote tumor growth and migration | [82] |
Melanoma | IL-1R-MYD88-Tet2 | Pro-M2 polarization | Attract MDSCs | [83] |
NPC | USP7/TRIM24/SPLUNC1 | Pro-M1 polarization | Repress tumor growth and migration | [84] |
HNSCC | miR-9/PPARδ/NF-κB | Pro-M1 polarization | Increase the radiosensitivity of HPV + HNSCC | [85] |
GBM | SLIT/ROBO/PI3K-γ | Pro-M2 polarization | Facilitate glioma growth and vascular dysmorphia | [38] |